Yehezkel Ben-Ari - Curriculum Vitae#
Education
- 1971 Docteur Es Science, Sorbonne University Paris
- 1973 - 1979 post-doctoral fellowships: University of Cambridge (United Kingdom), Oslo (Norway) and McGill (Canada)
Positions
- 1986- DIrector of INSERM U 29 (Paris)
- 1999- Founder and First director of Inmed (Mediterranean Institute of Neurobiology)
- 2011- Retirement & foundation of biotech companies:
- Neurochlore: Treatment of Autism Spectrum Disorders
- BABiomedical: Machine Learning identification at birth of babies who will have later a diagnosis of autism
- Baoncomedical: Novel treatments of brain tumours
- Neurochlore: Treatment of Autism Spectrum Disorders
- 2026-Founder of the Ben-Ari Institute of innovation (IBEN) that will host biotech companies
Scientific Responsibilities
- 1996 - 1999 Elected member of the scientific council, Inserm (France)
- 2005 - 2014 Scientific Advisory Board, Göttingen (Germany)
- 2003 - 2009 Scientific Committee of the Center of Neurosciences, Heidelberg University (Germany)
- 2006 Board of examiners of the University of excellence in the field of Neuroscience (Germany)
Teaching
- 2003 Professor at the doctorate school of Pasteur Institute, Paris (France)
- 2021 Teacher at the Neurosurgery Master course of the la Timone Hospital
Patents
- Antagonist of chloride cotransporters (NKCC1) in the treatment of Autism and other neurological and psychiatric diseases (Fragile X syndrome, Parkinson disease, Trisomy 21)
- Method and pharmaceutical composition for use in the treatment of glioblastoma
- Novel family of NKCC1 inhibitors
- Machine Learning program to identify children responding to Bumetanide
- Machine Learning Maternity analysis to identify at birth babies who will have later a diagnosis of Autism
Awards and Honors
- 2000 Grand Prix of the American Epilepsy Society (Milken foundation
- 2002 Grand Prix de la Santé of the EDF Foundation
- 2006 Rotary Club Award on brain research
- 2009 Grand Prix of the French Medical Research Council (Inserm)
- 2009 Docteur Honoris causa, University of Liège (Belgium)
- 2010 Grand Prix of the European Society of Epilepsy
- 2012 Grand Prix of the Belgium Research Foundation (Gagna Van Haeck Price -FNRS, Belgium)
- 2013 First prize, category: « Tremplins La Provence », 18th Economy Awards (Provence-Alpes-Côte d’Azur, France) Neurochlore
- 2014 4th prize for Neurochlore of the 23rd Créa13 Awards organized by the CG13 (Bouches-du-Rhône, France)
Books
The Amygdaloid complex, Plenum Press
Excitatory amino acids in epilepsies, Plenum Press
Treating autism with Bumetanide -Deboeck eds (French) and MacCauley eds (English)
The 1st 1000 days (Humensis eds (French) and Cambridge Scholar (English)
